Clinical trial
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
NCT00504023 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- January 31, 2018
- Enrollment
- 8 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
vulvar cancer